Thomas Reiberger
@ReibergerThomas
Followers
2K
Following
5K
Media
420
Statuses
1K
Professor of Hepatology @MedUni_Wien Director CD-Lab for #PortalHypertension & #LiverFibrosis Adjunct PI @CeMM_News & @LBI_RUD Head @CrgMOTION Secr @BavenoCoop
Vienna, Austria
Joined July 2021
@ViennaLiverNews Retreat Weekend 2024.Big Thanks 🙏 to all #VLSG and .@LBG_research @CrgMotion Members for discussing and defining the Vision #2025 for the @MedUni_Wien program for #ACLD #PortalHypertension
1
1
28
RT @JHEP_Reports: 📢Our August issue is out❗️. Featured article:.🟣Risk of portal hypertensive complications preventable by TIPS in patients….
0
13
0
Thank you Prof. Michael MANNS of Medizinische Hochschule Hannover (#MHH). He has been an inspiring mentor to me and many others. @HeinerWedemeyer @b_maasoumy @CornbergMarkus .I will very much remember his motivating and visionary speaches paired with kindness and appreciation.
EASL is deeply saddened to share the news of the passing of Professor Michael P. Manns (1951–2025). A visionary leader in hepatology, Professor Manns shaped the field through his pioneering research in viral hepatitis, autoimmune liver diseases, transplantation and regenerative
0
1
17
RT @get_ruben: Retrieval of LSECtin mitigates hepatic T cell inflammation through LAG-3 in experimental cirrhosis👇🏻..
pubmed.ncbi.nlm.nih.gov
LSECtin downregulation is associated with the expansion of Th17 cell subpopulation during cirrhosis. Findings highlight the crucial role of LSECtin in regulating immune responses and mitigating liver...
0
7
0
RT @EASLnews: 🌟 Registration and abstract submission now open for the EASL SLD Summit 2026! . 📅 26–28 February.📍 Budapest, Hungary. Explore….
0
5
0
RT @Yujun__Wong: 🔥Non-invasive testing in #recompensation in🍺. ❓What WORKS and what does NOT:. 🌟Liver stiffness measurement (LSM)>25 kPa: r….
0
17
0
Abstaining from alcohol can reverse the course of liver disease even with advanced cirrhosis
meduniwien.ac.at
1
7
20
RT @rabataller: Anytime a patient is referred to me with decompensated cirrhosis for transplant evaluation, I ask myself: is it possible to….
0
69
0
📕Editorial @hartl_md @MedUni_Wien in the.Journal of Clinical and Expertimental Hepatology. Revisiting the Role of Transjugular Transhepatic Portosystemic Shunt (#TIPS) for Portal Vein Recanalization #PVRTIPS in #Cirrhosis w Portal Vein Thrombosis #PVT. 🔗
2
13
26
RT @Dr_Ampuero: 🧵1/3. Today is #WorldHepatitisDay , and let’s see a recent study from @sapdes:. 🆕Recompensated cirrhosis after HCV cure (SV….
0
13
0
Collaborative Study @EASLnews .🇦🇹AT🇩🇰DE🇮🇹IT researchers have shown that the prognosis of #Patients wtih #Cirrhosis #Complications depends on the pattern of .#acute (AD) or #nonacute (NAD) #Decompensation . @AleksanderKrag @MedUni_Wien et al.
0
13
34
🌍#WorldHepatitisDay #2025.🇦🇹our contributions to #Hepatitis .1⃣ #HBV-ART in #HIV 🔗2⃣Curing #HCV in #HIV🔗3⃣Eliminate #HCV in 🇦🇹AT🔗4⃣Followup after #HCV cure🔗
0
1
3
RT @RautouE: 📢An overview on vascular involvement in chronic liver disease:.Everything on:.➡️ portal vein thrombosi….
0
28
0
9th European Club for Liver Cell Biology
easl.eu
The goal of the meeting is to allow junior physicians and scientistsfrom the field of cell biology and pathophysiology of the liver to share data and experiences.
0
1
6
NCBI Website Maintenance -- Beginning July 25th via @ncbi.
ncbiinsights.ncbi.nlm.nih.gov
On Friday, July 25th, starting at 9:00 PM EDT, we’ll be performing essential maintenance on the NLM data center. This upgrade is critical to ensure the continued reliability and stability of our...
0
0
0
RT @AleksanderKrag: Happy to share this RCT from @LiverGALAXY in people with ALD . Out today in @NaturePortfolio . .
0
16
0
REMEMBERING Professor JAUME BOSCH (@jaumebosch9) .President of Baveno @BavenoCoop .Friend and Mentor to many
5
10
46
😢 Thanks for Everything Jaume 🙏.
With deep sadness, we share the passing of Dr. Jaime Bosch — a visionary researcher, passionate physician, and cherished friend. Widely regarded as the father of portal hypertension, the Liver Unit of Barcelona will always be indebted to his immense legacy.
0
0
11